New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 24, 2014
12:07 EDTUPS, ARWR, HLF, GILD, AAPL, NUS, ISIS, POn The Fly: Midday Wrap
Stocks on Wall Street were lower at midday following reports on the state of manufacturing in the U.S., China and the European Union. The Purchasing Managers' Indexes, or PMIs, showed that manufacturing activity contracted last month in China but that it had expanded again in the U.S. and the EU. ECONOMIC EVENTS: In the U.S., Markit's manufacturing PMI for March fell to 55.5 from February's 57.1 reading. The reading was 1 point below the consensus forecast, but was still strongly in expansionary territory, as 50 is the dividing line between expansion and contraction. In China, Markit's flash PMI came in at 48.1, falling short of expectations for a 48.7 reading. In Europe, the PMI for the euro area as a whole came in at 53.2, which was just below last month's 32-month high reading of 53.3. COMPANY NEWS: Shares of Nu Skin Enterprises (NUS) surged nearly 19% near midday after the company's China business was penalized only $540,000 for direct sales of certain products. Nu Skin said it is already taking steps to correct the issues raised in the AIC reviews and that it is not aware of any other material enforcement investigations currently pending in China. Research firm Deutsche Bank said it expects Nu Skin to announce a "significant" share repurchase program over the next several quarters after the China investigation was resolved with "modest" fines. Deutsche thinks today's news lifts an overhang on Nu Skin and keeps a Buy rating on the stock with a $110 price target. Meanwhile shares of Nu Skin's multi-level marketing peer Herbalife (HLF), which has also been accused of impropriety in China, are up about 8%. Herbalife had its own news this morning as well, as it announced that it has amended and restated its agreement with Carl Icahn and will nominate three new Icahn designees for election to the company’s board. MAJOR MOVERS: Among the notable gainers was MicroVision (MVIS), which jumped 20% after announcing that it has agreed to supply customized PicoP display modules to shipping giant UPS (UPS). Also higher was Symantec (SYMC), which rose 2% after research firm BMO Capital upgraded the stock and said it believes all strategic options, including a sale or divestiture of underperforming assets, will be considered following the company's recent termination of its CEO. Among the noteworthy losers was Arrowhead Research (ARWR), which dropped more than 15%. Research firm Piper Jaffray attributed the move lower to competitor ISIS Pharmaceuticals (ISIS) having announced preclinical data on its own antisense compound targeting hepatitis B virus, which is a clinical area that Arrowhead is also exploring. A number of other biotechnology companies' shares were also lower, with Oppenheimer attributing the continued weakness in the sector to investor concerns that were sparked by a letter sent Friday by several members of Congress to Gilead (GILD) regarding the price of its Hepatits C drug, Sovaldi. Also lower were shares of Internet radio company Pandora (P), which slid almost 9% after Billboard reported on Friday that Apple (AAPL) is considering launching a new music service and is also weighing a new iTunes app for Android smartphones. INDEXES: Near midday, the Dow was down 52.55, or 0.32%, to 16,250.22, the Nasdaq was down 66.01, or 1.54%, to 4,210.78, and the S&P 500 was down 12.25, or 0.66%, to 1,854.27.
News For NUS;HLF;P;AAPL;ARWR;ISIS;GILD;UPS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | all recent news | >>
July 17, 2015
11:06 EDTAAPLOppenheimer predicts Apple high-end dominance to drive 'beat and raise' report
Subscribe for More Information
10:21 EDTGILDCigna says 98.4% of customers treated with hep C drug Harvoni are cured
Subscribe for More Information
09:35 EDTAAPLActive equity options trading on open
Active equity options trading on open: AAPL NFLX TSLA GOOG FB GOOGL SLB
09:03 EDTGILDGilead granted orphan status for gastric cancer treatment
Subscribe for More Information
07:44 EDTAAPLApple should deliver beat and raise Q3 results, says Oppenheimer
Subscribe for More Information
07:38 EDTAAPLApple July weekly volatility elevated into Q3 and outlook
Apple July call option implied volatility is at 25, July weekly 34, August is at 28, October is at 25; compared to its 52-week range of 15 to 36, suggesting large near term price movement into the expected release of Q3 results on July 21.
06:58 EDTAAPLApple Store employee suit reaches class action status, Reuters reports
Subscribe for More Information
July 16, 2015
18:26 EDTAAPLXiaomi VP says 'absolutely' coming to U.S., Bloomberg TV says
Subscribe for More Information
16:00 EDTAAPLOptions Update; July 16, 2015
iPath S&P 500 VIX Short-Term Futures down 1.17 to 16.52 Option volume leaders: NFLX AAPL BAC FB F INTC C EBAY AMZN GM JPM MU PFE BABA JD X
11:53 EDTAAPLApple and Samsung in talks to launch e-sim card, Financial Times reports
Apple (AAPL) and Samsung (SSNLF) are in advanced talks to launch electronic sim cards, reports the Financial Times. The GSMA is close to announcing an agreement to produce an standardized embedded sim for consumer devices that would include the smartphone makers. Reference Link
11:18 EDTAAPLReport: Apple considers axing iPad mini product, Business Insider says
Apple may be ending its iPad mini to focus on other products and specifically its larger iPads, reports Business Insider, citing a Chinese-language Economic Daily News report. Apple may also push the launch of its next-generation iPad Air to next year to emphasize its larger iPad. Reference Link
11:17 EDTAAPLApple July weekly volatility elevated into Q3 and outlook
Subscribe for More Information
09:35 EDTAAPLActive equity options trading on open
Subscribe for More Information
09:22 EDTGILDBristol-Myers says EU approves Evotaz for treatment of HIV-1 infection in adults
Subscribe for More Information
08:34 EDTAAPLSt. Jude Medical receives FDA approval for spinal cord stimulation trial system
St. Jude Medical (STJ) announced it received FDA approval of the Invisible Trial System. The system, which received CE Mark in June 2015, is fully wireless and leverages Apple (AAPL) technology for both the patient and physician controllers. The system is designed to provide patients a more improved and discreet spinal cord stimulation, or SCS, trial experience. "Patients undergoing SCS trials consistently tell us about challenges they find in navigating the SCS trial system, from programming the device, to discomfort from the programming cables, to management of both issues. These hindrances may impede the integration of the technology into their daily activities, which shifts their focus away from evaluating the effectiveness of SCS therapy,” said pain specialist Dr. Jason E. Pope, president of Summit Pain Alliance in Santa Rosa, California. “By providing a discreet trial system, St. Jude Medical will help patients focus more on their potential pain relief and functional improvements, and less about the burdens common to traditional trial systems.”
08:18 EDTAAPLSeveral stocks attractive following Intel results, says JMP Securities
For investors looking to take advantage of the sentiment shift the Intel (INTC) results could mean for the group and stronger demand due to seasonality and the Windows 10 launch, JMP Securities recommends Nvidia (NVDA) and Micron (MU). The firm says that both stocks have more attractive valuations and "more strategic roadmaps" than Intel. It also recommends Apple (AAPL) and Qualcomm (QCOM) as more attractive and secure dividend growth plays.
07:22 EDTAAPLiPhone average selling prices may be underestimated by Street, says UBS
Subscribe for More Information
07:19 EDTAAPLApple Q3 iPhone estimates raised at Stifel
Subscribe for More Information
06:58 EDTAAPLApple applies for patent for wireless devices with solar cells
Subscribe for More Information
06:46 EDTAAPLApple Watch to roll out in New Zealand July 31, AppleInsider reports
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use